Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $2.64 in the last session, down -5.04% from day before closing price of $2.78. In other words, the price has decreased by -$5.04 from its previous closing price. On the day, 0.53 million shares were traded. CMPX stock price reached its highest trading level at $2.7968 during the session, while it also had its lowest trading level at $2.63.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.33 and its Current Ratio is at 8.33. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 02, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform but kept the price unchanged to $6.
On February 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.Guggenheim initiated its Buy rating on February 24, 2025, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 27 ’25 when Schuetz Thomas J. bought 10,000 shares for $2.11 per share. The transaction valued at 21,100 led to the insider holds 6,480,825 shares of the business.
GORDON CARL L sold 3,571,428 shares of CMPX for $5,678,571 on Apr 09 ’25. The Director now owns 0 shares after completing the transaction at $1.59 per share. On Apr 09 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, sold 3,571,428 shares for $1.59 each. As a result, the insider received 5,678,571 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPX now has a Market Capitalization of 365064480 and an Enterprise Value of 253280496. For the stock, the TTM Price-to-Sale (P/S) ratio is 429.49 while its Price-to-Book (P/B) ratio in mrq is 3.31. Its current Enterprise Value per Revenue stands at 297.977 whereas that against EBITDA is -4.135.
Stock Price History:
The Beta on a monthly basis for CMPX is 1.28, which has changed by 2.0484989 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 19.44%, while the 200-Day Moving Average is calculated to be 25.26%.
Shares Statistics:
According to the various share statistics, CMPX traded on average about 995.41K shares per day over the past 3-months and 889790 shares per day over the past 10 days. A total of 138.28M shares are outstanding, with a floating share count of 87.95M. Insiders hold about 36.40% of the company’s shares, while institutions hold 43.20% stake in the company. Shares short for CMPX as of 1749772800 were 7389202 with a Short Ratio of 7.42, compared to 1747267200 on 6912500. Therefore, it implies a Short% of Shares Outstanding of 7389202 and a Short% of Float of 10.13.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
